Figure 1 (Image 01)
Relgaabi Capsule
Product Images NDC 58657-231
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Relgaabi (NDC 58657-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Method Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
This text appears to be a table displaying the mean pain scores over a 4-week period comparing a placebo to two different doses of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents the weeks of the study, and the y-axis shows the pain scores. This data may be part of a study or research comparing the effectiveness of Gabapentin for pain management.*
Figure 3 (Image 03)
Image-04 (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
This text provides information about a daily dose in milligrams along with a chart showing the percentage of the dose.*
Label (Label 231 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
